Matches in SemOpenAlex for { <https://semopenalex.org/work/W4366205611> ?p ?o ?g. }
- W4366205611 endingPage "15317" @default.
- W4366205611 startingPage "15306" @default.
- W4366205611 abstract "Purpose: Hyperlipidemia being the prominent risk factor of cardiovascular diseases and side effects associated with the current lipid-lowering drugs have attracted the interest of scientists in the quest for new alternatives. In view of the diverse pharmacological potentials of benzoxazole (BZX) compounds, this study was designed to evaluate the antihyperlipidemic activity of imine derivatives of BZX in high-fat diet (HFD)-fed rats. Methods: Hyperlipidemia was induced in Sprague-Dawley rats by using HFD for 28 days. On the 28th day, blood samples were collected, and animals having serum triglycerides (TG) greater than 400 mg/dL and total cholesterol (TC) greater than 280 mg/dL were selected for further study. Hyperlipidemic rats were daily treated with either a vehicle or simvastatin (SIM; 20 mg/kg) or BZX compounds (10, 20, and 30 mg/kg), for 12 consecutive days. After the specified time duration, hyperlipidemic biomarkers were evaluated in the blood samples of sacrificed rats. Liver samples were collected for histopathological and mRNA analyses. Binding affinities of BZX derivatives with different targets were assessed by molecular docking. Results: The present study revealed that the BZX derivatives dose-dependently reduced the serum levels of TC, TG, low-density lipoprotein, and very low-density lipoprotein along with improvement in high-density lipoprotein levels. Similarly, all the compounds reduced HFD-induced alanine transaminase and aspartate aminotransferase levels except BZX-4. Histopathology of liver samples demonstrated mild to moderate fatty changes upon treatment with BZX-1, BZX-2, and BZX-4. The hepatic architecture of the BZX-3-treated samples was close to normal, and only mild inflammation was witnessed in these samples. Moreover, all the compounds significantly increased superoxide dismutase and glutathione levels, indicating their antioxidant potentials. Gene expression data showed that BZX-1 and BZX-3 reduced lipid levels by inhibiting HMGCR, APOB, PCSK9, SRB1, and VCAM1 and via improving PPAR-α and APOE mRNA levels. BZX-2 demonstrated its antihyperlipidemic effects mainly due to inhibition of APOB, while BZX-4-mediated effects appeared to be due to attenuation of APOB, PCSK9, and SRB1. BZX derivatives displayed strong binding affinities with HMGCR, APOB, and VCAM1, which suggested that some of the interactions might be required for inhibition of these target proteins. Conclusions: Based on the current findings, it can be concluded that BZX derivatives exert their antihyperlipidemic effects via modulation of multiple lipid-regulating genes." @default.
- W4366205611 created "2023-04-19" @default.
- W4366205611 creator A5008820069 @default.
- W4366205611 creator A5020485638 @default.
- W4366205611 creator A5059481127 @default.
- W4366205611 creator A5068994305 @default.
- W4366205611 creator A5069687370 @default.
- W4366205611 creator A5075094133 @default.
- W4366205611 creator A5077077824 @default.
- W4366205611 creator A5086617764 @default.
- W4366205611 date "2023-04-17" @default.
- W4366205611 modified "2023-09-25" @default.
- W4366205611 title "Imine Derivatives of Benzoxazole Attenuate High-Fat Diet-Induced Hyperlipidemia by Modulation of Lipid-Regulating Genes" @default.
- W4366205611 cites W1506569093 @default.
- W4366205611 cites W1603987175 @default.
- W4366205611 cites W1604487092 @default.
- W4366205611 cites W1887624773 @default.
- W4366205611 cites W1920171370 @default.
- W4366205611 cites W1965151258 @default.
- W4366205611 cites W1973065853 @default.
- W4366205611 cites W1979829829 @default.
- W4366205611 cites W1989892910 @default.
- W4366205611 cites W1991932125 @default.
- W4366205611 cites W1996186320 @default.
- W4366205611 cites W2013980112 @default.
- W4366205611 cites W2032768670 @default.
- W4366205611 cites W2035747079 @default.
- W4366205611 cites W2052837798 @default.
- W4366205611 cites W2054354183 @default.
- W4366205611 cites W2056516296 @default.
- W4366205611 cites W2063313335 @default.
- W4366205611 cites W2073785836 @default.
- W4366205611 cites W2082374255 @default.
- W4366205611 cites W2083049470 @default.
- W4366205611 cites W2106611664 @default.
- W4366205611 cites W2109450490 @default.
- W4366205611 cites W2134967712 @default.
- W4366205611 cites W2151580122 @default.
- W4366205611 cites W2151714890 @default.
- W4366205611 cites W2154088758 @default.
- W4366205611 cites W2236488484 @default.
- W4366205611 cites W2236777524 @default.
- W4366205611 cites W2620436731 @default.
- W4366205611 cites W2800755231 @default.
- W4366205611 cites W2802427453 @default.
- W4366205611 cites W2886084256 @default.
- W4366205611 cites W2890786563 @default.
- W4366205611 cites W2950959314 @default.
- W4366205611 cites W2971068597 @default.
- W4366205611 cites W3007638452 @default.
- W4366205611 cites W3010648510 @default.
- W4366205611 cites W3016762617 @default.
- W4366205611 cites W3046286637 @default.
- W4366205611 cites W3095673375 @default.
- W4366205611 cites W3125313120 @default.
- W4366205611 cites W3129253407 @default.
- W4366205611 cites W3153219628 @default.
- W4366205611 cites W3153311054 @default.
- W4366205611 cites W3165590944 @default.
- W4366205611 cites W3183254330 @default.
- W4366205611 cites W3188381337 @default.
- W4366205611 cites W4214857365 @default.
- W4366205611 cites W4220871763 @default.
- W4366205611 cites W4220887504 @default.
- W4366205611 cites W4226154407 @default.
- W4366205611 cites W4236708854 @default.
- W4366205611 cites W4281386831 @default.
- W4366205611 cites W4307410701 @default.
- W4366205611 cites W98152484 @default.
- W4366205611 doi "https://doi.org/10.1021/acsomega.3c00443" @default.
- W4366205611 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/37151544" @default.
- W4366205611 hasPublicationYear "2023" @default.
- W4366205611 type Work @default.
- W4366205611 citedByCount "1" @default.
- W4366205611 countsByYear W43662056112023 @default.
- W4366205611 crossrefType "journal-article" @default.
- W4366205611 hasAuthorship W4366205611A5008820069 @default.
- W4366205611 hasAuthorship W4366205611A5020485638 @default.
- W4366205611 hasAuthorship W4366205611A5059481127 @default.
- W4366205611 hasAuthorship W4366205611A5068994305 @default.
- W4366205611 hasAuthorship W4366205611A5069687370 @default.
- W4366205611 hasAuthorship W4366205611A5075094133 @default.
- W4366205611 hasAuthorship W4366205611A5077077824 @default.
- W4366205611 hasAuthorship W4366205611A5086617764 @default.
- W4366205611 hasBestOaLocation W43662056111 @default.
- W4366205611 hasConcept C126322002 @default.
- W4366205611 hasConcept C134018914 @default.
- W4366205611 hasConcept C139572402 @default.
- W4366205611 hasConcept C160160445 @default.
- W4366205611 hasConcept C178790620 @default.
- W4366205611 hasConcept C181199279 @default.
- W4366205611 hasConcept C185592680 @default.
- W4366205611 hasConcept C2776329913 @default.
- W4366205611 hasConcept C2778047396 @default.
- W4366205611 hasConcept C2778163477 @default.
- W4366205611 hasConcept C2778270857 @default.
- W4366205611 hasConcept C2778606649 @default.
- W4366205611 hasConcept C2778913445 @default.